• Wednesday 4th March

    Panels, Keynotes & Workshops

    Times (CET)

    Location: Sofitel The Grand, Amsterdam

    08:15 - Registration Opens

    09:00 - Opening Remarks

    Opening Remarks by Cillian King, Partner, EQT Life Sciences

    09:10 - Panel Session: RNA-targeted medicines: a new frontier in neuroscience drug development

    Moderator: Arno de Wilde, Managing Director, EQT

    Panellists:

    Jack O'Meara, CEO, Aerska

    Joanne Kotz, CEO, Atalanta Therapeutics

    Rebecca Canter, Executive Director - Ventures, Eli Lilly & Company

    Paul Bridges, President, Consulting, Parexel

    11:00 - 12:00 De-Risking Clinical Trials When You Only Get One Shot [RSVP ONLY]

    When your company depends on one trial, surprises aren’t an option. Join this executive session to learn how biotechs can identify trial risks early, stay in control with CRO partners, and avoid costly delays that threaten runway and valuation.

    13:40 - Panel Session: From incorporation to exit: Imcheck, the CEO, the Buyer, the supporters

    Moderator: Vincent Brichard, Partner, EQT LS

    Panellists:

    Alexander Elias, Partner, Centerview Partners

    Pierre d’Epenoux, Former CEO, Imcheck

    Philippe Lopes-Fernandes, Head of BD, Ipsen

    Rose Mistri Somers, Managing Director, Russell Reynolds

    14:00 - 15:00 EMA EU Competitivenes: Regulatory support tools for innovative medicines and technologies developers [RSVP ONLY]

    17:00 - 19:00 Drinks Reception

    17:15 - Driving Healthcare Innovation: 25 years of Biocapital & 25 years of Impact

    Official launch by René Kuijten, Head of EQT Life Sciences.

    With:

    - Prof Anton Pijpers on behalf of Utrecht University

    - Prof Douwe Breimer on behalf of Leiden University

    - Prof Hans van Goudoever on behalf of Amsterdam University

    - Prof Stefan Sleijfer on behalf of Erasmus University of Rotterdam

  • Wednesday 4th March

    Medtech Track

    Times (CET) & Presenting Company

    Use drop down for speaker information

  • Biopharma Track

    Times (CET) & Presenting Company

  • Neuroscience Track

    Times (CET) & Presenting Company

  • Providing VCs and Institutional Investors access to 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe.

  • Organised by EQT Life Sciences

    EQT Life Sciences was formed in 2022 following an integration of LSP, a leading European life sciences and healthcare venture capital firm, into the EQT platform.
     
    As LSP, the firm raised over EUR 3.0 billion (USD 3.5 billion) and supported the growth of more than 150 companies since it started to invest over 30 years ago. With a dedicated team of highly experienced investment professionals, coming from backgrounds in medicine, science, business, and finance, EQT Life Sciences backs the smartest inventors who have ideas that could truly make a difference for patients.

    The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek.
     
    EQT Life Sciences’ broad life sciences and healthcare network is highly complementary to EQT’s global healthcare sector franchise and makes EQT an even better and more innovative healthcare investor.
     
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More